Macrophage fatty acid oxidation inhibits atherosclerosis progression.
暂无分享,去创建一个
Chengyu Liu | T. Finkel | Y. Mukouyama | Jie Liu | M. Wolfgang | H. Kawagishi | Zu-Xi Yu | I. Rovira | T. Yamazaki | Ye Yan | Mitsunori Nomura
[1] P. Carmeliet,et al. Quiescent Endothelial Cells Upregulate Fatty Acid β-Oxidation for Vasculoprotection via Redox Homeostasis. , 2018, Cell metabolism.
[2] G. V. D. Windt,et al. Fatty Acid Oxidation in Macrophages and T Cells : Time for Reassessment? , 2018 .
[3] Ajit S. Divakaruni,et al. Etomoxir Inhibits Macrophage Polarization by Disrupting CoA Homeostasis. , 2018, Cell metabolism.
[4] J. Auwerx,et al. Increased cardiac fatty acid oxidation in a mouse model with decreased malonyl-CoA sensitivity of CPT1B , 2018, Cardiovascular research.
[5] P. Tontonoz,et al. Liver X receptors in lipid signalling and membrane homeostasis , 2018, Nature Reviews Endocrinology.
[6] K. Moore,et al. Regulation of macrophage immunometabolism in atherosclerosis , 2018, Nature Immunology.
[7] S. Ferdinandusse,et al. Disorders of mitochondrial long-chain fatty acid oxidation and the carnitine shuttle , 2018, Reviews in Endocrine and Metabolic Disorders.
[8] R. Mynatt,et al. A low fat diet ameliorates pathology but retains beneficial effects associated with CPT1b knockout in skeletal muscle , 2017, PloS one.
[9] T. Hartung,et al. Loss of Hepatic Mitochondrial Long-Chain Fatty Acid Oxidation Confers Resistance to Diet-Induced Obesity and Glucose Intolerance. , 2017, Cell reports.
[10] L. O’Neill,et al. Macrophage Immunometabolism: Where Are We (Going)? , 2017, Trends in immunology.
[11] M. Horton,et al. Loss of macrophage fatty acid oxidation does not potentiate systemic metabolic dysfunction. , 2017, American journal of physiology. Endocrinology and metabolism.
[12] Sujoy Ghosh,et al. Mitochondrial fat oxidation is essential for lipid-induced inflammation in skeletal muscle in mice , 2016, Scientific Reports.
[13] M. Colonna,et al. Metabolic Reprogramming Mediated by the mTORC2-IRF4 Signaling Axis Is Essential for Macrophage Alternative Activation. , 2016, Immunity.
[14] S. Ryter,et al. NOX4-dependent fatty acid oxidation promotes NLRP3 inflammasome activation in macrophages , 2016, Nature Medicine.
[15] J. Rathmell,et al. A guide to immunometabolism for immunologists , 2016, Nature Reviews Immunology.
[16] S. Scafidi,et al. Hepatic Fatty Acid Oxidation Restrains Systemic Catabolism during Starvation. , 2016, Cell reports.
[17] T. Finkel,et al. Fatty acid oxidation in macrophage polarization , 2016, Nature Immunology.
[18] R. Wanders,et al. The Biochemistry and Physiology of Mitochondrial Fatty Acid β-Oxidation and Its Genetic Disorders. , 2016, Annual review of physiology.
[19] Dudley Lamming,et al. Akt-mTORC1 signaling regulates Acly to integrate metabolic input to control of macrophage activation , 2016, eLife.
[20] Jihong Han,et al. Inhibition of Glutathione Production Induces Macrophage CD36 Expression and Enhances Cellular-oxidized Low Density Lipoprotein (oxLDL) Uptake* , 2015, The Journal of Biological Chemistry.
[21] Xianlin Han,et al. Impaired mitochondrial fat oxidation induces adaptive remodeling of muscle metabolism , 2015, Proceedings of the National Academy of Sciences.
[22] F. Villarroya,et al. Enhanced fatty acid oxidation in adipocytes and macrophages reduces lipid-induced triglyceride accumulation and inflammation. , 2015, American journal of physiology. Endocrinology and metabolism.
[23] Maxim N. Artyomov,et al. Cell-intrinsic lysosomal lipolysis is essential for macrophage alternative activation , 2014, Nature Immunology.
[24] N. Ferreirós,et al. Inhibition of macrophage fatty acid β-oxidation exacerbates palmitate-induced inflammatory and endoplasmic reticulum stress responses , 2014, Diabetologia.
[25] K. Moore,et al. Macrophages in atherosclerosis: a dynamic balance , 2013, Nature Reviews Immunology.
[26] M. Hersberger,et al. Fatty acid–induced mitochondrial uncoupling elicits inflammasome-independent IL-1α and sterile vascular inflammation in atherosclerosis , 2013, Nature Immunology.
[27] Kathryn E. Crosier,et al. Immunoresponsive gene 1 augments bactericidal activity of macrophage-lineage cells by regulating β-oxidation-dependent mitochondrial ROS production. , 2013, Cell metabolism.
[28] Christine E. Becker,et al. CD36 coordinates NLRP3 inflammasome activation by facilitating the intracellular nucleation from soluble to particulate ligands in sterile inflammation , 2013, Nature Immunology.
[29] Johan Auwerx,et al. The metabolic footprint of aging in mice , 2011, Scientific reports.
[30] Denis Gris,et al. Fatty acid–induced NLRP3-ASC inflammasome activation interferes with insulin signaling , 2011, Nature Immunology.
[31] J. Tschopp,et al. A role for mitochondria in NLRP3 inflammasome activation , 2011, Nature.
[32] A. Chawla. Control of macrophage activation and function by PPARs. , 2010, Circulation research.
[33] K. Moore,et al. NLRP3 inflamasomes are required for atherogenesis and activated by cholesterol crystals that form early in disease , 2010, Nature.
[34] S. Watkins,et al. Reducing endoplasmic reticulum stress through a macrophage lipid chaperone alleviates atherosclerosis , 2009, Nature Medicine.
[35] D. Greaves,et al. Oxidative metabolism and PGC-1beta attenuate macrophage-mediated inflammation. , 2006, Cell metabolism.
[36] W. Reith,et al. Conditional gene targeting in macrophages and granulocytes using LysMcre mice , 1999, Transgenic Research.
[37] R. Evans,et al. PPARγ Promotes Monocyte/Macrophage Differentiation and Uptake of Oxidized LDL , 1998, Cell.
[38] E. Rubin,et al. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells , 1992, Cell.